BUP 30MG/ HYDROM 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800

Lack of sterility assurance.

Recall #: D-0700-2020
Affected scope: 1 syringe
Initiated: December 20, 2019

Compiled from official public sources by the publisher. · Updated September 2026

Assurance Infusion recalled BUP 30MG/ HYDROM 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800 - a moderate-severity action.

BUP 30MG/ HYDROM 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800 was recalled by Assurance Infusion in January 22, 2020. Reason: Lack of sterility assurance.. Check the official notice for the remedy. Verify recall #D-0700-2020 with the FDA Drug before acting.

The recall

Assurance Infusion issued this moderate-severity FDA Drug recall-Lack of sterility assurance..

Moderate
severity level: Class II
classification: January 22, 2020
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0700-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

BUP 30MG/ HYDROM 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800

Reason for recall

Lack of sterility assurance.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-0700-2020
Date reported	January 22, 2020
Date initiated	December 20, 2019
Recalling firm	Assurance Infusion
Firm location	Houston, TX
Affected scope	1 syringe
Distribution	Nationwide within the United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0700-2020) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

BUP 30MG/ HYDROM 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800. Recalled by Assurance Infusion. Units affected: 1 syringe.

Why was this product recalled? ▼

Lack of sterility assurance.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on January 22, 2020. Severity: Moderate. Recall number: D-0700-2020.

Where was the recalled product distributed? ▼

Distribution: Nationwide within the United States.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Ketorolac Tromethamine Injection, USP 60 … 2020-01-22 Sumatriptan Succinate Tablets, 50 mg, pac… 2020-01-22 Sumatriptan Succinate Tablets, 100 mg pa… 2020-01-22 Dutasteride Capsules, 0.5 mg, 30 Capsules… 2020-01-22

Similar Medical Devices · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

CARESCAPE Respiratory Module E-sCO 2020-01-22 CARESCAPE Respiratory Module E-sCOVX 2020-01-22 CARESCAPE Respiratory Module E-sCAiO 2020-01-22 CARESCAPE Respiratory Module E-sCAiOV 2020-01-22

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Drug, reported January 22, 2020. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026